… compared with chemotherapy when given as first-line treatment for Asian patients with non-…
for first-line treatment of European patients with advanced EGFR-mutation positive NSCLC. …

… treatment allocation. Our primary outcome was the eradication rate in first-line treatment by
intention-to-treat … sequential treatment as the standard first-line treatment for H pylori infection. …

Background We aimed to examine cemiplimab, a programmed cell death 1 inhibitor, in the
first-line treatment of advanced non-small-cell lung cancer with programmed cell death ligand …

… In this open-label, multicentre, phase 2 trial, we enrolled treatment-naive patients with
advanced lung cancer who had clinical (never-smokers [<100 cigarettes per lifetime] or former …

… (TKIs) have greater first-line efficacy than does chemotherapy in EGFR mutation-positive
NSCLC. We recommend that EGFR TKIs be regarded as the first-line treatment of choice for this …

… an uncontrolled, open-label, phase II study of regorafenib as second-line therapy in patients
with … cycles of 3 weeks on treatment followed by 1 week off treatment as the recommended …

… We aimed to investigate whether starting first-line IFX (FL-IFX) is more effective to achieve
and maintain remission than conventional treatment. Design In this multicentre open-label …

… regimen could provide an alternative to standard of care with the EXTREME regimen in the
first-line treatment … who might not be good candidates for up-front pembrolizumab treatment. …

… First-line treatment with atezolizumab monotherapy was associated with improved overall
… These data support atezolizumab monotherapy as a potential first-line treatment option for …

… The study was open label, so neither investigators nor participants were masked to
treatment assignment. However, drug concentration analysis for the primary pharmacokinetic …